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Previewssuggesting that the contribution of Stat3
in creating a poised state for reprogram-
ming is achieved via regulation of addi-
tional yet-to-be-identified target genes.
Future studies aimed at uncovering the
molecular and biochemical nature of this
primed intermediate state may be highly
relevant for demystifying the black box
of reprogramming.
Smith and colleagues (Yang et al.,
2010) extended these findings further in
different in vitro reprogramming experi-
mental settings. Somatic neural precur-
sor cells expressing the chimeric Gcsf
receptor were generated and shown to
be reprogrammed more efficiently after
exogenous expression of Oct4 and Klf4
when in the presence of Gcsf. Similarly,
the effect of Gcsf-induced Stat3 activa-
tion was analyzed in a partially reprog-
rammed intermediate cell line derived
from embryonic fibroblasts (Silva et al.,
2008). This intermediate line has not reac-
tivated endogenous pluripotency genes
nor silenced the Oct4, Sox2, Klf4, and
c-Myc transgenes. Cooperative action of
Gcsf and 2i accelerated the kinetics and
yielded an 8-fold increase in the efficiency
of generating Oct4-GFP+ cells from the
partially reprogrammed iPSC line. Naive
pluripotent cells derived throughout the
studyshared traits that definenaivemouse276 Cell Stem Cell 7, September 3, 2010 ª20ESCs, includinggeneexpressionpatterns,
cell signaling dependence, activation of
both X chromosomes in female cell lines,
and competence to generate high-contri-
bution chimeric animals (Nichols and
Smith, 2009). Notably, althoughStat3 acti-
vation dramatically facilitated the induc-
tion of pluripotency in the different experi-
mental settings applied, Stat3 signaling
was not found to be a ‘‘roadblock’’ for
this process, because iPSCs did arise,
albeit at reduced efficiency, even when
this signaling pathway was actively in-
hibited via specific small molecules.
The findings reported by the Smith
group (Yang et al., 2010) provide conclu-
sive evidence that exogenous signaling
stimuli and paracrine factors play a direct
role in positively or negatively regulating
the induction of murine naive pluripotency
(Figure 1). Further, these results corrobo-
rate recent reports that characterized the
involvement of different signaling path-
ways in regulating ESC growth and iPSC
reprogramming (Hanna et al., 2009a; Silva
et al., 2008) and collectively underscore
striking redundancy and similarities
between the determinants involved in (1)
maintaining naive pluripotent cells in vitro
(ESCs or iPSCs) and inducing naive pluri-
potency (2) in somatic cells or (3) in primed
EpiSCs (Figure 1) and provocatively insin-10 Elsevier Inc.uate that themolecular pathways and rate
limiting step underlying these processes
(Hannaet al., 2009b)maybehighly similar,
if not identical.
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Although hematopoietic stem cells (HSCs) reside in hypoxic niches, the significance of hypoxia signaling in
HSCs remains unclear. In this issue of Cell Stem Cell, Takubo et al. (2010) and Simsek et al. (2010) demon-
strate that hypoxia regulates the metabolic state of HSCs and protects their integrity by controlling HIF-1a.Multipotent hematopoietic stem cells
(HSCs) reside in niches within the bone
marrow (BM) and have a unique capacity
to sustain life-long multilineage hemato-poiesis (Orkin and Zon, 2008). HSCs
face tightly orchestrated cell fate deci-
sions between quiescence, self-renewal,
apoptosis, and differentiation. Althoughthe precise integrated mechanisms that
underlie HSC fate decisions are poorly
understood, it is generally accepted that
their choices are regulated by both
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Previewsintrinsic factors and extrinsic cues pro-
vided by their niches. Recent studies
have suggested that the microenviron-
ment harboring HSCs exhibits low oxygen
levels (Parmar et al., 2007). These findings
raise some fundamental questions: how
do HSCs adapt to and utilize chronic local
hypoxia and how might these processes
impact HSC fate decisions? In this issue
ofCell StemCell, two groups use comple-
mentary approaches to provide important
insights into the role of hypoxia and its
signaling pathways in regulating HSC
functions (Simsek et al., 2010; Takubo
et al., 2010).
Cellular responses to hypoxia aremedi-
ated by hypoxia-inducible factors (HIFs),
which regulate gene expression in order
to facilitate an adaptation to the hypoxic
conditions (Kaelin and Ratcliffe, 2008).
Simsek et al. (2010) demonstrate that
adult HSCs have elevated levels of
HIF-1a (an alpha subunit of HIF-1) and
increased expression of hypoxia-induc-
ible genes, including those controlling
glycolysis. As a consequence, HSCs alter
their metabolism and exhibit increased
rates of glucose consumption and lactate
production and decreased rates of mito-
chondrial oxidative phosphorylation and
oxygen consumption compared to ma-
ture BM cells. This study therefore pro-
vides evidence that HSCs adapt to the
hypoxic microenvironment within stem
cell niches by utilizing glycolysis instead
of mitochondrial oxidative phosphoryla-
tion. Whether or not a functional Krebs
cycle is required for normal HSC functions
remains unclear. This question could be
addressed by using existing mouse
models that harbor mutations in mito-
chondrial enzymes.
In the second paper, Takubo et al.
(2010) conditionally delete HIF-1a and
observe a loss of quiescence specifically
in the HSC compartment. HIF-1a-defi-
cient HSCs have an increased cell cycling
rate and show progressive loss of long-
term repopulation capacity in serial trans-
plantation assays. Interestingly, although
HIF-1a is critical for HSC maintenance
under conditions of hematopoietic stress
(i.e., transplantation or myelosuppres-
sion), under physiological conditions,
HIF-1a-deficient HSCs sustain hemato-
poiesis for a prolonged period. It would
be of interest to investigate mechanisms
through which HSCs lacking HIF-1a, an
essential regulator of metabolic adapta-tion to hypoxia, survive and function
under hypoxic conditions before they
eventually lose their activity.
Takubo et al. also demonstrate that
monoallelic deletion of Von Hippel-Lindau
(VHL) protein, an E3 ubiquitin ligase that
normally mediates HIF-1a degradation
(Kaelin and Ratcliffe, 2008), and the con-
sequent HIF-1a stabilization increases
the fraction of quiescent HSCs and results
in their expansion in transplanted re-
cipients. Paradoxically, ablation of both
alleles of VHL and overstabilization of
HIF-1a enhances quiescence of HSCs,
but instead of HSC expansion it leads to
a striking loss of HSC activity upon trans-
plantation. These experiments therefore
indicated that levels of HIF-1a that are
either too low or too high are deleterious
for HSC functions. Collectively, Takubo
et al. provide genetic evidence that
HIF-1a is an essential regulator of HSC
quiescence and that strict regulation of
HIF-1a is pivotal for the long-termmainte-
nance of HSCs.
Although little is known about the
regulation of HIF-1a functions in stem
cells, it is becoming clear that HIF-1a is
kept in check at multiple levels. Takubo
et al. elegantly show that HSCs residing
within the hypoxic zone of the BM main-
tain intracellular hypoxia and stabilize
HIF-1a. It is likely that the stabilization of
HIF-1a in vivo is caused by local hypoxia
and cytokine signaling, because both of
these stimuli stabilize the HIF-1a protein.
Simsek et al. shed light on the transcrip-
tion of HIF-1a in HSCs by demonstrating
that the homeodomain protein Meis1,
which is essential for hematopoiesis
(Hisa et al., 2004), directly activates
HIF-1a expression. It will be of interest
to investigate whether hematopoietic
defects observed in Meis1-deficient
mice, such as the competitive disadvan-
tage ofMeis1mutant HSCs, are mediated
by defective HIF-1a expression. Finally,
the regulation of the transcriptional
activity of HIF-1a may also play critical
roles in HSC maintenance. For example,
we showed that conditional deletion of
Cited2, a negative regulator of HIF-1a-
mediated transcription, results in
dramatic loss of HSCs (Kranc et al.,
2009). The findings by Takubo et al.
showing that enhanced HIF-1a function
(observed in HSCs lacking both VHL
alleles) has a detrimental impact on the
HSC pool and can, at least in part, explainCell Stem Cell 7, Sthe phenotype observed in Cited2-
deficient HSCs. Further studies are clearly
required to provide insights into HIF-1a
regulation in HSCs.
The identification of hypoxia and the
HIF-1 system as major regulators of
HSCs provides important insights into
HSC functions. In the emerging model,
quiescent HSCs residing in hypoxic
niches sense the hypoxic microenviron-
ment and stabilize a key regulator of
stem cell maintenance, HIF-1, which
activates transcription of target genes
including those required for the adapta-
tion to glycolysis as the main source of
energy. Consistent with this hypothesis,
hypoxic in vitro conditions maintain the
quiescent phenotype of mouse HSCs
(Eliasson et al., 2010). Although HSCs
require a strict regulation of HIF-1a to sus-
tain quiescence, themechanisms through
which HIF-1a promotes quiescence
remain unexplained. Hypoxia-induced
quiescence may be a consequence of
slow metabolic rates in HSCs. Alterna-
tively, HIF-1 may activate the expression
of genes controlling HSC quiescence. In
fact, a direct target gene of HIF-1, Foxo3a,
is essential for the quiescent phenotype of
HSCs (Miyamoto et al., 2007). Further-
more, studies in other systems have re-
vealed that in addition to genes regulating
energy metabolism, HIF-1 controls tran-
scription of more than 100 genes involved
in multiple cellular processes including
the cell cycle, survival, differentiation,
and autophagy (Kaelin and Ratcliffe,
2008), suggesting that hypoxia signaling
may also be critical for HSC fates other
than quiescence.
Hypoxia signaling may be an important
and general feature of other stem cell
niches. Indeed, it is proposed that HIF
promotes the generation of cancer stem
cells and regulates dedifferentiation and
self-renewal. In this context, HIF has
been shown to activate Notch signaling
and to regulate Oct4 and c-Myc (Mohyel-
din et al., 2010). These processes may
also be relevant to cancers in individuals
harboring mutations that inactivate the
Krebs cycle enzymes, where, similar to
the HSC metabolism described by
Simsek et al., HIF and glycolytic metabo-
lism are constitutively active.
We are only beginning to understand
the role of hypoxia and its signaling
pathways in stem cell functions. Consid-
erable effort needs to be invested ineptember 3, 2010 ª2010 Elsevier Inc. 277
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Previewsaddressing important questions sur-
rounding stem cell niches and the
impact of their hypoxic microenviron-
ment on HSC fate decisions in vivo.
Are all quiescent BM-resident HSCs
localized in a hypoxic microenviron-
ment? How do different levels of HSC
oxygenation (e.g., during HSC mobiliza-
tion from the BM to the peripheral blood)
impact on their functions? Which stem
cell fates does hypoxia promote? What
are the key HIF target genes essential
for the maintenance of the HSC pool?
The findings presented in this issue of
Cell Stem Cell set the stage for further
investigations in this fascinating and ex-
panding field.278 Cell Stem Cell 7, September 3, 2010 ª20REFERENCES
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